Event info
Date:10 Nov
Time:12:00 - 18:30
Venue:Copenhagen, Denmark

Annual Meeting 2017 – Health, Wealth and World Class

Medicon Valley Alliance’s Annual Meeting 2017 is inspired by the Danish life science growth team´s recommendation published in March, which emphasized better health, more wealth and growth and more world class R&D within life science.

This year we focus on the parallel processes where Denmark and Sweden are developing their national life science strategies, and where we hope to see the unique bi-national Danish-Swedish perspective reflected in both national strategies. A perspective that will also be addressed in the presentation of “State of Medicon valley 2017 – an analysis of life science in Greater Copenhagen”. The analysis will be distributed at the meeting.

Based on the huge interest in last year´s topic, we have decided to continue the inspiring discussion about funding of innovation and the challenges relating to start-up, scale-up and commercialization of innovation.

Date: Friday November 10, 2017
Time: 12.00 – 18.00
Venue: Crowne Plaza, Ørestads Boulevard 114-118, 2300 Copenhagen, Denmark

 

12:00 – 12:30

Registration, networking and sandwiches

12:30 – 12:35

Welcome
Petter Hartman, CEO, Medicon Valley Alliance & Anne Mette Hvass, Senior Sales Manager, BC Hospitality Group A/S

12:35 – 12:50

State of Medicon Valley – Life science in Greater Copenhagen
Petter Hartman, CEO, Medicon Valley Alliance

12:50 – 13:10

How can Medicon Valley benefit from a Danish life science strategy?
Ida Sofie Jensen, Director General, LIF – Danish Association of the Pharmaceutical Industry

13:10 – 13:25

A Swedish Agenda for health and prosperity
Anna Nilsson Vindefjärd, Founder and Secretary General, Research!Sweden, Member of the Swedish
governments 
expert board on life science

13:25 – 14:00

The Swiss Health Valley
Patrick Aebischer, Prof. Dr. med. Swiss Federal Institute of Technology

14:00 – 14:30

 Coffee break & networking

14:30 – 14:45

Lundbeckfonden – Better life through new knowledge
Christian Elling, Managing Partner, Lundbeckfonden Emerge

14:45 – 15:00

Life science VC investments in an evolving funding landscape
Jonas Jendi, Investment Manager, Industrifonden

15:00 – 15:20

Turning discovery into innovation through collaboration
Anna Gran, New Ventures Lead, Nordics , Johnson & Johnson Innovation

15:20 – 15:40

Lounge interview

15:40 – 16:10

Coffee break & networking

16:10 – 16:30

Danish National Biobank a unique national institution, a unique regional opportunity
Lasse Boding, Head of Coordinating Centre, Danish National Biobank, Statens Serum Institut

16:30 – 16:50

How to fund life science innovation – the Zealand Pharma perspective
Britt Meelby Jensen, President and CEO, Zealand Pharma

16:50 – 17:10

Why do we believe in Nordic Life Science?
Elisabeth Björk, VP, Late Clinical Development, AstraZeneca 

 17:10 – 17:30

Navigating healthcare transformation by pursuing greater value
Henrik Rindel Gudbergsen, Chief Medical Officer, IBM Nordic

17:30 – 17:35

Summary and conclusions
Søren Bregenholt, Chairman of the MVA board, Corporate Vice President, Novo Nordisk A/S

17:35 – 18:30

Networking & tapas

SPEAKERS

The list of speakers will be updated on an ongoing basis.

Patrick Aebischer
Prof. Dr. med.
Swiss Federal Institute of Technology

Elisabeth Björk
VP, Late Clinical Development
AstraZeneca 

Lasse Boding
Head of Coordinating Centre
Danish National Biobank
Statens Serum Institut

Søren Bregenholt
Chairman of the board
Corporate Vice President
Novo Nordisk A/S 

Christian Elling
Managing Partner
Lundbeckfonden Emerge

Anna Gran
New Ventures Lead, Nordics
Johnson & Johnson Innovation

Jonas Jendi
Investment Manager
Industrifonden

Petter Hartman
CEO
Medicon Valley Alliance

Britt Meelby Jensen
President and CEO
Zealand Pharma

Ida Sofie Jensen
Director General
LIF – Danish Association of
the Pharmaceutical Industry

Anna Nilsson Vindefjärd
Founder and Secretary General
Research!Sweden
Member of the Swedish governments
expert board on life science

Henrik Rindel Gudbergsen
Chief Medical Officer
IBM Nordic  

   

Morten Sommer
Professor
Technical University of Denmark 

  

 

Raise questions and follow discussions

For this year’s annual meeting we will use a system called Slido. Slido is a simple system which can be used for asking questions to speakers and to follow the discussions among the audience. The moderator will follow the dialogue on Slido and will pick questions to be asked to the speaker after each presentation. Questions can also be asked during the Q&A after each presentation.

To use Slido open your web browser (e.g. Safari/Google Chrome) on your smartphone.

Type in slido.com

Enter the following code: 1726      Choose MVA Annual Meeting 2017

Please find a more detailed description of how to use Slido here.

MVA’s Annual meeting is the annual flagship event of Medicon Valley Alliance. We invite prominent regional, national and international speakers to address key topics such as life science innovation, commercialization of R&D, public private partnerships, talent attraction and other issues of importance for the realization of our vision for the Medicon Valley cluster. Last year’s annual meeting entitled “How to fund life science innovation”, was attended by 250+ prominent regional life science stakeholders and among other things included a guest appearance by then US. Ambassador to Denmark, Rufus Gifford.

SPONSORS

 

 Imprimir

250px-JMPlogo

 

 

Do you want to become a sponsor of the Annual Meeting? Contact David Zepernick, dz@mva.org or (+45) 24 98 16 68.

PARTICIPATION

Participation is free of charge for members of MVA and members of the press (late cancellation* /no-show fee DKK 500 excl. VAT).
For non-members, the participant fee is DKK 1.500 excl. VAT, please see our event policy for non-members participation (late cancellation* /no-show fee DKK 500 excl. VAT).
Registration ends on November 8, 2017.
* If you cancel after the registration ends, it is considered late cancellation.